Boundless Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2023 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Boundless Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q4 2024.
Boundless Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $2.01M, a 120% increase year-over-year.
Boundless Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $7.52M, a 125% increase year-over-year.
Boundless Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $7.52M, a 125% increase from 2023.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2024	$7.52M	$2.01M	+$1.1M	+120%	Oct 1, 2024	Dec 31, 2024	10-K	2025-03-27
Q3 2024	$6.42M	$2.05M	+$1.16M	+132%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$5.26M	$2.14M	+$1.21M	+130%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$4.05M	$1.33M	+$713K	+116%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$3.34M	$911K			Oct 1, 2023	Dec 31, 2023	10-K	2025-03-27
Q3 2023		$883K			Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023		$927K			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-12
Q1 2023		$615K			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.